US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

3.83

-0.1000-2.54%

Post-market: 3.80-0.0300-0.78%19:55 EDT

Volume:892.40K

Turnover:3.45M

Market Cap:123.31M

PE:-2.64

High:4.12

Open:3.98

Low:3.78

Close:3.93

Loading ...

Overview Company News Filings

Top Penny Stocks To Watch In April 2025

Simply Wall St.

Holding(s) in Company

ProQR Appoints Dennis Hom as CFO, Cristina Lopez as CMO

MT Newswires Live

Sagimet Biosciences: Promising Future with Phase 3 MASH Trials and Strong Financial Position

Sagimet Biosciences Price Target Announced at $32.00/Share by HC Wainwright & Co.

Sagimet Biosciences Faces AI Integration Challenges: Security, Compliance, and Cost Risks Loom

Sagimet Biosciences Advances MASH Treatment with New Trials

Sagimet Biosciences Price Target Maintained With a $32.00/Share by HC Wainwright & Co.

Sagimet Biosciences’ Strategic Expansion into Acne Treatment with Promising FASN Inhibitor TVB-3567

Sagimet Reports Acne Drug Candidate Cleared for Clinical Trials

MT Newswires Live

Sagimet Biosciences receives FDA nod to begin testing its therapy for acne

Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne

Is Sagimet Biosciences Inc. (SGMT) the Best Get Rich Quick Stock to Invest In?

BRIEF-Sagimet Biosciences Announces Oral Presentation At The Mash Pathogenesis And Therapeutic Approaches Keystone Symposium

Sagimet Biosciences Announces Oral Presentation at the Mash Pathogenesis and Therapeutic Approaches Keystone Symposium

THOMSON REUTERS

Sagimet Biosciences Announces Oral Presentation at the MASH Pathogenesis and Therapeutic Approaches Keystone Symposium

Buy Recommendation for Sagimet Biosciences: Denifanstat’s Unique Profile and Undervaluation Offer Compelling Investment Opportunity

BUZZ-JonesTrading starts coverage on drug developer Sagimet with 'buy' rating

Sagimet Biosciences Inc : Jonestrading Initiates Coverage With Buy Rating; Price Target $42

THOMSON REUTERS

Sagimet Biosciences initiated with a Buy at JonesResearch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SGMT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":3.83,"timestamp":1746216000000,"preClose":3.93,"halted":0,"volume":892398,"hourTrading":{"tag":"盘后","latestPrice":3.8,"preClose":3.83,"latestTime":"19:55 EDT","volume":2407,"amount":9134.1695,"timestamp":1746230131987},"delay":0,"floatShares":20491361,"shares":32195345,"eps":-1.453459,"marketStatus":"Market Closed","change":-0.1,"latestTime":"05-02 16:00:00 EDT","open":3.98,"high":4.12,"low":3.78,"amount":3452739.9780432,"amplitude":0.086514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.453459,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":3.93,"preHourTrading":{"tag":"盘前","latestPrice":4.04,"preClose":3.93,"latestTime":"09:29 EDT","volume":924,"amount":3658.521636,"timestamp":1746192576287},"postHourTrading":{"tag":"盘后","latestPrice":3.8,"preClose":3.83,"latestTime":"19:55 EDT","volume":2407,"amount":9134.1695,"timestamp":1746230131987},"volumeRatio":1.7062787668036197,"impliedVol":2.1328,"impliedVolPercentile":0.7094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","floatShares":20491361,"roa":"-26.49%","roe":"-36.92%","lyrEps":-1.453459,"volumeRatio":1.7062787668036197,"shares":32195345,"dividePrice":0,"high":4.12,"amplitude":0.086514,"preClose":3.93,"low":3.78,"week52Low":1.73,"pbRate":"0.79","week52High":7.38,"institutionHeld":0,"latestPrice":3.83,"eps":-1.453459,"divideRate":0,"volume":892398,"delay":0,"ttmEps":-1.453459,"open":3.98,"prevYearClose":4.5,"prevWeekClose":3.15,"prevMonthClose":3.45,"prevQuarterClose":3.26,"fiveDayClose":3.15,"twentyDayClose":2.27,"sixtyDayClose":5.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGMT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530966470","title":"Top Penny Stocks To Watch In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530966470","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530966470?lang=en_us&edition=fundamental","pubTime":"2025-04-25 02:05","pubTimestamp":1745517911,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a surge, driven by positive earnings reports and anticipation of tariff news, investors are paying close attention to potential opportunities across various sectors. For those willing to explore beyond established giants, penny stocks—often representing smaller or newer companies—remain an intriguing option. Despite being considered somewhat outdated, these stocks can still offer significant growth potential when backed by strong financials and sound fundamentals. In this article, we highlight three penny stocks that stand out for their balance sheet strength and potential for impressive returns.Overview: Origin Materials, Inc. operates as a carbon-negative materials company with a market cap of $102.24 million.Click here and access our complete financial health analysis report to understand the dynamics of Origin Materials.Gain insights into Origin Materials' outlook and expected performance with our report on the company's earnings estimates.Overv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-penny-stocks-watch-april-180511198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","BK4139","SGMT","BK4209","TTI","BK4021","PLX","TUYA","BK4505","BK4023","ORGNW","SB","BK4563","BK4090","BK4526","BK4509","BK4179","ORGN"],"gpt_icon":0},{"id":"2529549459","title":"Holding(s) in Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2529549459","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529549459?lang=en_us&edition=fundamental","pubTime":"2025-04-23 14:01","pubTimestamp":1745388060,"startTime":"0","endTime":"0","summary":"DIVERSIFIED ENERGY COMPANY PLC  announces that, in accordance with the terms of its share buyback programme announced on 20 March 2025, the Company has purchased 60,300 Ordinary Shares of 20 Pence each in the capital of the Company  in the market at a volume-weighted average price of $11.9682 per Share through Mizuho Securities USA LLC . The Shares acquired will, in due course, be cancelled.Following the cancellation of Shares, Diversified will have 80,498,562 Ordinary Shares of 20 Pence each in issue and no Ordinary Shares are held in treasury. This figure of 80,498,562 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.In accordance with Article 5 of Regulation  No 596/2014 , , the table below contains detailed information of the individual trades made by Peel Hunt as part of the buybac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/holding-company-060100494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARCX","BK4156","EU","BK4213","DEC","BK4139","USD","SGMT"],"gpt_icon":0},{"id":"2527196615","title":"ProQR Appoints Dennis Hom as CFO, Cristina Lopez as CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2527196615","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527196615?lang=en_us&edition=fundamental","pubTime":"2025-04-14 22:54","pubTimestamp":1744642499,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics  said Monday it appointed Dennis Hom as chief financial officer and Cristina Lopez as chief medical officer.Hom joins the company from Sagimet Biosciences , where he most recently was head of corporate development and CFO, ProQR added. He will succeed Jurriaan Dekkers, who is stepping down as finance chief but will remain during the transition period.Lopez most recently served as global head of neurodegeneration at Johnson & Johnson .ProQR's stock was down 2.2% in recent Monday trading.Price: 1.10, Change: -0.03, Percent Change: -2.23","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2347655156.SGD","LU1718418525.SGD","PRQR","LU0466842654.USD","LU2133065610.SGD","LU1066053197.SGD","LU0912757837.SGD","LU2430703095.HKD","LU0345769128.USD","LU1057294990.SGD","SG9999001440.SGD","IE00B7SZLL34.SGD","LU0114720955.EUR","BK4139","LU2430703251.USD","LU2602419157.SGD","IE00B3PB1722.GBP","IE00BSNM7G36.USD","LU1066051811.HKD","LU1196500208.SGD","LU0058720904.USD","IE00BDGV0183.EUR","LU1244550221.USD","LU1732800096.USD","LU1430594728.SGD","LU2430703178.SGD","BK4533","BK4534","LU1929549753.HKD","IE00B1BXHZ80.USD","BK4559","IE00B19Z3581.USD","IE00BBT3K403.USD","LU1221951129.SGD","LU0098860793.USD","LU0985320562.USD","LU0203347892.USD","LU1732799900.SGD","LU2592432038.USD","IE00B2B36J28.USD","LU1506573853.SGD","IE0009355771.USD","SGMT","IE00BLSP4452.SGD","JNJ","LU1914381329.SGD","LU2129689514.USD","LU1267930813.SGD","LU0122379950.USD","LU1032466523.USD"],"gpt_icon":0},{"id":"2519819178","title":"Sagimet Biosciences: Promising Future with Phase 3 MASH Trials and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2519819178","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519819178?lang=en_us&edition=fundamental","pubTime":"2025-03-14 10:55","pubTimestamp":1741920924,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A (SGMT) has received a new Buy rating, initiated by TD Cowen analyst, Ritu Baral. Ritu Baral has given her Buy rat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sagimet-biosciences-promising-future-with-phase-3-mash-trials-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sagimet-biosciences-promising-future-with-phase-3-mash-trials-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2519882553","title":"Sagimet Biosciences Price Target Announced at $32.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2519882553","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519882553?lang=en_us&edition=fundamental","pubTime":"2025-03-13 18:43","pubTimestamp":1741862580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2025 06:43 ET (10:43 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2519160070","title":"Sagimet Biosciences Faces AI Integration Challenges: Security, Compliance, and Cost Risks Loom","url":"https://stock-news.laohu8.com/highlight/detail?id=2519160070","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519160070?lang=en_us&edition=fundamental","pubTime":"2025-03-13 14:01","pubTimestamp":1741845696,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A (SGMT) has disclosed a new risk, in the Technology category. Sagimet Biosciences, Inc. Class A faces significant ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-faces-ai-integration-challenges-security-compliance-and-cost-risks-loom?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-faces-ai-integration-challenges-security-compliance-and-cost-risks-loom?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2519489079","title":"Sagimet Biosciences Advances MASH Treatment with New Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2519489079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519489079?lang=en_us&edition=fundamental","pubTime":"2025-03-13 12:11","pubTimestamp":1741839064,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A ( ($SGMT) ) has released its Q4 earnings. Here is a breakdown of the information Sagimet Biosciences, Inc. Class ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-advances-mash-treatment-with-new-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sagimet-biosciences-advances-mash-treatment-with-new-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2518486722","title":"Sagimet Biosciences Price Target Maintained With a $32.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2518486722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518486722?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:13","pubTimestamp":1741713180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 11, 2025 13:13 ET (17:13 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2518872263","title":"Sagimet Biosciences’ Strategic Expansion into Acne Treatment with Promising FASN Inhibitor TVB-3567","url":"https://stock-news.laohu8.com/highlight/detail?id=2518872263","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518872263?lang=en_us&edition=fundamental","pubTime":"2025-03-12 00:55","pubTimestamp":1741712122,"startTime":"0","endTime":"0","summary":"Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report). The ass...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sagimet-biosciences-strategic-expansion-into-acne-treatment-with-promising-fasn-inhibitor-tvb-3567?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sagimet-biosciences-strategic-expansion-into-acne-treatment-with-promising-fasn-inhibitor-tvb-3567?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2518728991","title":"Sagimet Reports Acne Drug Candidate Cleared for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728991","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518728991?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:45","pubTimestamp":1741704326,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences  said Tuesday the US Food and Drug Administration's Division of Dermatology and Dentistry has cleared its investigational new drug application for TVB-3567.The company said the clearance allows it to enter clinical development for the treatment of acne, with a first-in-human phase 1 trial planned in 2025.TVB-3567 is its second fatty acid synthase inhibitor, it said.Price: 3.37, Change: -0.17, Percent Change: -4.80","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00511","BK4139","BK1145","SGMT"],"gpt_icon":0},{"id":"2518740705","title":"Sagimet Biosciences receives FDA nod to begin testing its therapy for acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2518740705","media":"Reuters","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518740705?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:46","pubTimestamp":1741700798,"startTime":"0","endTime":"0","summary":"March 11 (Reuters) - Sagimet Biosciences Inc ::*SAGIMET BIOSCIENCES ANNOUNCES CLEARANCE OF IND FOR FASN INHIBITOR TVB-3567, TO BE DEVELOPED FOR THE TREATMENT OF ACNE*SAGIMET BIOSCIENCES INC - FIRST-IN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nRSD3wjKBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2518450748","title":"Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2518450748","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518450748?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:00","pubTimestamp":1741694400,"startTime":"0","endTime":"0","summary":"TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 SAN MATEO, Calif., March  11, 2025  (GLOBE NEWSWIRE) -- Sagimet Bioscience","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040476/0/en/Sagimet-Biosciences-Announces-Clearance-of-IND-for-FASN-Inhibitor-TVB-3567-to-be-Developed-for-the-Treatment-of-Acne.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK1145","BK4139","00511"],"gpt_icon":0},{"id":"2514091393","title":"Is Sagimet Biosciences Inc. (SGMT) the Best Get Rich Quick Stock to Invest In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091393","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091393?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:25","pubTimestamp":1740489922,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Get Rich Quick Stocks To Invest In.In this article, we are going to take a look at where Sagimet Biosciences Inc.  stands against the other stocks.Those are some of the big questions in the aftermath of the S&P 500 posting a 23% gain in 2024, building on a 24% gain in 2023.If history is anything to go by, the likelihood of US equity markets finishing at a high for a third consecutive year is low. \"Historically, the likelihood is about 1 in 5,\" says Sam Stovall, chief investment strategist at CFRA. While history tends to repeat itself, the chief investment strategist believes there is a high chance that investors will enjoy significant returns, as has been the case in the past two years.\"Our preferred sectors in a world of supply chain strain driven by multipolar escalation and/or new tariffs vary by region — in some regions there are clear sector implications while in others it is about identifying relative opportunities within sectors. In the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sagimet-biosciences-inc-sgmt-best-132522198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2089283258.USD","BK4504","LU1668664300.SGD","LU1162221912.USD","LU0106261372.USD","LU1363072403.SGD","BK4581","BK4139","LU1989772840.SGD","LU2271345857.HKD","BK4585","SGMT","BK4588","LU1732799900.SGD","LU0267386448.USD","LU2111349929.HKD","LU2133065610.SGD","LU1720051108.HKD","LU1074936037.SGD","LU2347655156.SGD","IE00BZ1G4Q59.USD","BK4534","LU0971096721.USD","LU0006306889.USD","LU1720051017.SGD","LU0158827948.USD","LU1989772923.USD","LU2023251221.USD","LU2089284900.SGD","IE00BKVL7J92.USD","LU0106831901.USD","LU0314104364.USD","BK4127","BK4516","LU0912757837.SGD","LU0225283273.USD","LU0320765646.SGD","LU0795875169.SGD","LU1548497426.USD","LU2357305700.SGD","LU2028103732.USD","LU0158827781.USD","LU0098860793.USD","LU0795875086.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2512485544","title":"BRIEF-Sagimet Biosciences Announces Oral Presentation At The Mash Pathogenesis And Therapeutic Approaches Keystone Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512485544?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:03","pubTimestamp":1739977391,"startTime":"0","endTime":"0","summary":"BRIEF-Sagimet Biosciences Announces Oral Presentation At The Mash Pathogenesis And Therapeutic Approaches Keystone SymposiumFeb 19 (Reuters) - Sagimet Biosciences Inc SGMT.O:SAGIMET BIOSCIENCES ANNOUN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA5LFWHX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2512014111","title":"Sagimet Biosciences Announces Oral Presentation at the Mash Pathogenesis and Therapeutic Approaches Keystone Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2512014111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512014111?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA5LFWHX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2512091101","title":"Sagimet Biosciences Announces Oral Presentation at the MASH Pathogenesis and Therapeutic Approaches Keystone Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2512091101","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512091101?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., Feb.  19, 2025  (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctiona","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/19/3028721/0/en/Sagimet-Biosciences-Announces-Oral-Presentation-at-the-MASH-Pathogenesis-and-Therapeutic-Approaches-Keystone-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2508266181","title":"Buy Recommendation for Sagimet Biosciences: Denifanstat’s Unique Profile and Undervaluation Offer Compelling Investment Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2508266181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508266181?lang=en_us&edition=fundamental","pubTime":"2025-02-04 01:27","pubTimestamp":1738603648,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A (SGMT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst De...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/uncategorized/buy-recommendation-for-sagimet-biosciences-denifanstats-unique-profile-and-undervaluation-offer-compelling-investment-opportunity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/uncategorized/buy-recommendation-for-sagimet-biosciences-denifanstats-unique-profile-and-undervaluation-offer-compelling-investment-opportunity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2506153377","title":"BUZZ-JonesTrading starts coverage on drug developer Sagimet with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2506153377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506153377?lang=en_us&edition=fundamental","pubTime":"2025-01-27 21:55","pubTimestamp":1737986158,"startTime":"0","endTime":"0","summary":"BUZZ-JonesTrading starts coverage on drug developer Sagimet with 'buy' rating** JonesTrading starts coverage on drug developer Sagimet Biosciences SGMT.O with \"buy\" rating, sets PT at $42** PT represents 900% upside to stock's last close** Brokerage says co's experimental drug, denifanstat, is \"overlooked potential\" in treating metabolic dysfunction-associated steatohepatitis ** MASH is a severe liver disease caused by fat buildup, leading to inflammation and damage** JonesTrading notes denifanstat has \" best-in-disease potential for fibrosis improvement as GLP-1 combo\" with \"well-derisked lead asset\" in expanding market** Brokerage says it estimates peak sales of $1.6 bln for denifanstat in 2034** SGMT fell 15.6% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON0XG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2506376163","title":"Sagimet Biosciences Inc : Jonestrading Initiates Coverage With Buy Rating; Price Target $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2506376163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506376163?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:13","pubTimestamp":1737980021,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3ON0SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2506375740","title":"Sagimet Biosciences initiated with a Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2506375740","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506375740?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:55","pubTimestamp":1737978942,"startTime":"0","endTime":"0","summary":"JonesResearch initiated coverage of Sagimet Biosciences (SGMT) with a Buy rating and $42 price target The firm says its bullish outlook is driven b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-initiated-with-a-buy-at-jonesresearch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-initiated-with-a-buy-at-jonesresearch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGMT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGMT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGMT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1738036800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGMT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGMT","date":"2025-05-02","current":-2.77674,"percent":0.904206,"low":-15.666506,"twenty":-7.146955,"median":-4.575776,"eighty":-3.219588,"high":-1.342444,"avg":-5.398048,"sd":2.829902,"marketCap":126527705},"quantilePoints":[{"date":"2023-07-21","current":-12.287206,"twenty":-13.337015,"median":-12.553129,"eighty":-11.625533,"marketCap":348354576},{"date":"2023-07-28","current":-12.208993,"twenty":-12.714826,"median":-12.49838,"eighty":-12.113574,"marketCap":346137170},{"date":"2023-08-04","current":-12.733018,"twenty":-12.595364,"median":-12.529665,"eighty":-12.271563,"marketCap":360993794},{"date":"2023-08-11","current":-12.514023,"twenty":-12.565643,"median":-12.517933,"eighty":-12.42486,"marketCap":354785056},{"date":"2023-08-18","current":-9.925184,"twenty":-12.565643,"median":-12.514023,"eighty":-12.265307,"marketCap":281388897},{"date":"2023-08-25","current":-9.359416,"twenty":-12.554693,"median":-12.471006,"eighty":-10.020915,"marketCap":262381858},{"date":"2023-09-01","current":-9.85717,"twenty":-12.553129,"median":-12.459274,"eighty":-9.809842,"marketCap":276335907},{"date":"2023-09-08","current":-10.126447,"twenty":-12.543743,"median":-12.279385,"eighty":-9.775571,"marketCap":283884818},{"date":"2023-09-15","current":-9.791891,"twenty":-12.532793,"median":-11.532454,"eighty":-9.775571,"marketCap":274505868},{"date":"2023-09-22","current":-8.282308,"twenty":-12.524972,"median":-10.126447,"eighty":-9.674388,"marketCap":232186213},{"date":"2023-09-29","current":-7.392878,"twenty":-12.517151,"median":-9.936056,"eighty":-9.403479,"marketCap":207251930},{"date":"2023-10-06","current":-5.866975,"twenty":-12.514023,"median":-9.90613,"eighty":-8.80291,"marketCap":164474765},{"date":"2023-10-13","current":-4.757227,"twenty":-12.495252,"median":-9.80821,"eighty":-7.764969,"marketCap":133364100},{"date":"2023-10-20","current":-3.729078,"twenty":-12.478045,"median":-9.791891,"eighty":-6.978354,"marketCap":104540984},{"date":"2023-10-27","current":-3.647479,"twenty":-12.474916,"median":-9.751091,"eighty":-6.462648,"marketCap":102253435},{"date":"2023-11-03","current":-3.100765,"twenty":-12.467095,"median":-9.681732,"eighty":-5.866975,"marketCap":86926858},{"date":"2023-11-10","current":-2.284775,"twenty":-12.467095,"median":-9.514454,"eighty":-4.757227,"marketCap":64051369},{"date":"2023-11-17","current":-1.981702,"twenty":-12.459274,"median":-9.396135,"eighty":-4.030995,"marketCap":53347428},{"date":"2023-11-24","current":-3.487116,"twenty":-12.32162,"median":-9.116089,"eighty":-3.455541,"marketCap":93873157},{"date":"2023-12-01","current":-3.248971,"twenty":-12.280949,"median":-8.665823,"eighty":-3.326797,"marketCap":87462307},{"date":"2023-12-08","current":-3.436085,"twenty":-12.223071,"median":-7.870232,"eighty":-3.326797,"marketCap":92499403},{"date":"2023-12-15","current":-4.74588,"twenty":-11.827315,"median":-7.466317,"eighty":-3.305106,"marketCap":127759077},{"date":"2023-12-22","current":-4.79691,"twenty":-11.412789,"median":-6.927763,"eighty":-3.326797,"marketCap":129132830},{"date":"2023-12-29","current":-5.009539,"twenty":-10.856914,"median":-6.462648,"eighty":-3.351567,"marketCap":134856803},{"date":"2024-01-05","current":-4.286601,"twenty":-10.142767,"median":-6.27497,"eighty":-3.385054,"marketCap":115395295},{"date":"2024-01-12","current":-6.055674,"twenty":-10.126447,"median":-6.038333,"eighty":-3.402064,"marketCap":163018751},{"date":"2024-01-19","current":-5.494334,"twenty":-10.061168,"median":-5.928097,"eighty":-3.422477,"marketCap":147907462},{"date":"2024-01-26","current":-11.924235,"twenty":-11.412789,"median":-6.047003,"eighty":-3.434384,"marketCap":321000405},{"date":"2024-02-02","current":-11.8484,"twenty":-11.755197,"median":-6.332089,"eighty":-3.449693,"marketCap":318958920},{"date":"2024-02-09","current":-7.10904,"twenty":-11.755197,"median":-6.72671,"eighty":-3.480312,"marketCap":191375352},{"date":"2024-02-16","current":-10.260714,"twenty":-11.412789,"median":-7.18072,"eighty":-3.487116,"marketCap":276218424},{"date":"2024-02-23","current":-7.973973,"twenty":-11.272575,"median":-7.393401,"eighty":-3.512632,"marketCap":214659353},{"date":"2024-03-01","current":-7.263069,"twenty":-10.976358,"median":-7.495026,"eighty":-3.600344,"marketCap":195521817},{"date":"2024-03-08","current":-7.642218,"twenty":-10.478725,"median":-7.466317,"eighty":-3.696438,"marketCap":205728503},{"date":"2024-03-15","current":-5.118509,"twenty":-10.189946,"median":-7.39314,"eighty":-3.910228,"marketCap":137790253},{"date":"2024-03-22","current":-5.509506,"twenty":-10.132975,"median":-7.18072,"eighty":-4.056781,"marketCap":148315897},{"date":"2024-03-28","current":-6.56,"twenty":-10.093807,"median":-7.132737,"eighty":-4.084178,"marketCap":182866572},{"date":"2024-04-05","current":-6.239442,"twenty":-10.00568,"median":-6.795721,"eighty":-4.174333,"marketCap":173930684},{"date":"2024-04-12","current":-5.976126,"twenty":-9.938231,"median":-6.56,"eighty":-4.313817,"marketCap":166590490},{"date":"2024-04-19","current":-4.545061,"twenty":-9.925184,"median":-6.397368,"eighty":-4.392065,"marketCap":126698131},{"date":"2024-04-26","current":-4.487819,"twenty":-9.917562,"median":-6.217851,"eighty":-4.458405,"marketCap":125102437},{"date":"2024-05-03","current":-5.09459,"twenty":-9.886546,"median":-6.182199,"eighty":-4.468439,"marketCap":142016797},{"date":"2024-05-10","current":-5.231972,"twenty":-9.844114,"median":-6.079163,"eighty":-4.479356,"marketCap":145846463},{"date":"2024-05-17","current":-5.429865,"twenty":-9.811474,"median":-6.018678,"eighty":-4.487871,"marketCap":151590963},{"date":"2024-05-24","current":-5.372708,"twenty":-9.791891,"median":-5.987575,"eighty":-4.491214,"marketCap":149995268},{"date":"2024-05-31","current":-6.172899,"twenty":-9.791891,"median":-5.987575,"eighty":-4.501006,"marketCap":172334989},{"date":"2024-06-07","current":-5.315552,"twenty":-9.783731,"median":-5.976126,"eighty":-4.523122,"marketCap":148399574},{"date":"2024-06-14","current":-5.47559,"twenty":-9.751091,"median":-5.952111,"eighty":-4.533251,"marketCap":152867518},{"date":"2024-06-21","current":-4.446773,"twenty":-9.731508,"median":-5.91688,"eighty":-4.519544,"marketCap":124145020},{"date":"2024-06-28","current":-4.698262,"twenty":-9.718452,"median":-5.91688,"eighty":-4.523122,"marketCap":131166075},{"date":"2024-07-05","current":-3.257919,"twenty":-9.685812,"median":-5.888477,"eighty":-4.48795,"marketCap":90954577},{"date":"2024-07-12","current":-3.738033,"twenty":-9.677652,"median":-5.800519,"eighty":-4.448199,"marketCap":104358410},{"date":"2024-07-15","current":-3.806621,"twenty":-9.67602,"median":-5.796735,"eighty":-4.447058,"marketCap":106273243},{"date":"2024-08-02","current":-3.97809,"twenty":-9.674388,"median":-5.79295,"eighty":-4.391494,"marketCap":111060326},{"date":"2024-08-09","current":-3.109312,"twenty":-9.635837,"median":-5.632964,"eighty":-4.048186,"marketCap":86805772},{"date":"2024-08-16","current":-3.011259,"twenty":-9.556995,"median":-5.529634,"eighty":-3.765468,"marketCap":88082328},{"date":"2024-08-23","current":-3.174914,"twenty":-9.5049,"median":-5.509506,"eighty":-3.626007,"marketCap":92869411},{"date":"2024-08-30","current":-3.36039,"twenty":-9.480538,"median":-5.47559,"eighty":-3.517501,"marketCap":98294771},{"date":"2024-09-06","current":-2.913065,"twenty":-9.458966,"median":-5.429865,"eighty":-3.459899,"marketCap":85210078},{"date":"2024-09-13","current":-3.709522,"twenty":-9.418167,"median":-5.410329,"eighty":-3.440029,"marketCap":108507215},{"date":"2024-09-20","current":-3.578597,"twenty":-9.3382,"median":-5.372708,"eighty":-3.459899,"marketCap":104677549},{"date":"2024-09-27","current":-3.076721,"twenty":-9.217671,"median":-5.306102,"eighty":-3.426198,"marketCap":89997161},{"date":"2024-10-04","current":-4.495067,"twenty":-9.063099,"median":-5.281258,"eighty":-3.402458,"marketCap":131485214},{"date":"2024-10-11","current":-4.516888,"twenty":-9.008144,"median":-5.226248,"eighty":-3.408396,"marketCap":132123492},{"date":"2024-10-18","current":-5.891593,"twenty":-8.972181,"median":-5.273199,"eighty":-3.426198,"marketCap":172334989},{"date":"2024-10-25","current":-6.000697,"twenty":-8.935294,"median":-5.292689,"eighty":-3.429281,"marketCap":175526378},{"date":"2024-10-31","current":-5.826131,"twenty":-8.894301,"median":-5.311818,"eighty":-3.436085,"marketCap":170420156},{"date":"2024-11-08","current":-6.753511,"twenty":-8.791513,"median":-5.372708,"eighty":-3.436763,"marketCap":197546960},{"date":"2024-11-15","current":-5.651565,"twenty":-8.755967,"median":-5.41811,"eighty":-3.453095,"marketCap":165313934},{"date":"2024-11-22","current":-3.861691,"twenty":-8.665823,"median":-5.372708,"eighty":-3.487116,"marketCap":144879052},{"date":"2024-11-29","current":-4.882893,"twenty":-8.557843,"median":-5.315552,"eighty":-3.487116,"marketCap":183191513},{"date":"2024-12-06","current":-3.998995,"twenty":-8.332016,"median":-5.292689,"eighty":-3.504949,"marketCap":150030307},{"date":"2024-12-13","current":-3.896017,"twenty":-8.272608,"median":-5.273199,"eighty":-3.525595,"marketCap":146166866},{"date":"2024-12-20","current":-4.350838,"twenty":-8.042693,"median":-5.190447,"eighty":-3.550034,"marketCap":163230399},{"date":"2024-12-27","current":-4.35942,"twenty":-7.978712,"median":-5.107971,"eighty":-3.56885,"marketCap":163552352},{"date":"2025-01-03","current":-3.853109,"twenty":-7.96022,"median":-5.094591,"eighty":-3.578236,"marketCap":144557099},{"date":"2025-01-10","current":-4.608284,"twenty":-7.932249,"median":-5.088866,"eighty":-3.585335,"marketCap":172889002},{"date":"2025-01-17","current":-3.664315,"twenty":-7.891035,"median":-5.014451,"eighty":-3.578519,"marketCap":137474123},{"date":"2025-01-24","current":-3.561337,"twenty":-7.843641,"median":-5.001034,"eighty":-3.577995,"marketCap":133610681},{"date":"2025-01-31","current":-3.484103,"twenty":-7.800873,"median":-4.931489,"eighty":-3.565628,"marketCap":130713100},{"date":"2025-02-07","current":-4.041903,"twenty":-7.796247,"median":-4.899965,"eighty":-3.577995,"marketCap":151640074},{"date":"2025-02-14","current":-3.775875,"twenty":-7.711114,"median":-4.882893,"eighty":-3.5785,"marketCap":141659518},{"date":"2025-02-21","current":-3.454068,"twenty":-7.655997,"median":-4.848447,"eighty":-3.56477,"marketCap":129586263},{"date":"2025-02-28","current":-3.097934,"twenty":-7.585345,"median":-4.824006,"eighty":-3.534402,"marketCap":116225195},{"date":"2025-03-07","current":-3.13226,"twenty":-7.533213,"median":-4.786117,"eighty":-3.487116,"marketCap":117513009},{"date":"2025-03-14","current":-2.479989,"twenty":-7.4778,"median":-4.774032,"eighty":-3.471231,"marketCap":113005660},{"date":"2025-03-21","current":-2.861526,"twenty":-7.417463,"median":-4.751553,"eighty":-3.434384,"marketCap":130391147},{"date":"2025-03-28","current":-2.656626,"twenty":-7.395771,"median":-4.728869,"eighty":-3.400275,"marketCap":121054497},{"date":"2025-04-04","current":-1.603868,"twenty":-7.392983,"median":-4.702859,"eighty":-3.36039,"marketCap":73083433},{"date":"2025-04-11","current":-1.575606,"twenty":-7.289031,"median":-4.694849,"eighty":-3.31696,"marketCap":71795619},{"date":"2025-04-17","current":-1.42723,"twenty":-7.21366,"median":-4.648098,"eighty":-3.301626,"marketCap":65034596},{"date":"2025-04-25","current":-2.204435,"twenty":-7.173257,"median":-4.603993,"eighty":-3.254074,"marketCap":100449476},{"date":"2025-05-02","current":-2.77674,"twenty":-7.146955,"median":-4.575776,"eighty":-3.219588,"marketCap":126527705}],"updateTime":1746292487442}}}